Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Olson

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2020
Examining geographic accessibility to radiotherapy in Canada and Greenland for indigenous populations: Measuring inequities to inform solutionsJessica Chan, Jeppe Friborg, Eduardo Zubizarreta, et al.
Briefings in Bioinformatics|August 11, 2021
A genomic data resource for predicting antimicrobial resistance from laboratory-derived antimicrobial susceptibility phenotypesMargo VanOeffelen, Marcus Nguyen, Derya Aytan-Aktug, et al.
BMC Cancer|October 6, 2018
Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5Robert Olson, Mitchell Liu, Alanah Bergman, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 2022
Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized TrialMatthew Van Oirschot, Alanah Bergman, Wilko F A R Verbakel, et al.
JAMA Network Open|February 3, 2026
Stereotactic Body Radiotherapy Without Systemic Therapy for Oligometastatic Cancer: A Systematic Review and Meta-AnalysisJonas Willmann, Camilla von Wachter, Ronja Zehnder, et al.
Plos Biology|November 9, 2006
The marine viromes of four oceanic regionsFlorent E Angly, Ben Felts, Mya Breitbart, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2019
Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized TrialRobert Olson, Suresh Senan, Stephen Harrow, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2014
High-throughput comparison, functional annotation, and metabolic modeling of plant genomes using the PlantSEED resourceSamuel M D Seaver, Svetlana Gerdes, Océane Frelin, et al.
Biochimica Et Biophysica Acta|March 23, 2011
Connecting genotype to phenotype in the era of high-throughput sequencingChristopher S Henry, Ross Overbeek, Fangfang Xia, et al.
The American Journal of Pathology|July 25, 2021
Trajectory of Growth of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Houston, Texas, January through May 2021, Based on 12,476 Genome SequencesRandall J Olsen, Paul A Christensen, S Wesley Long, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2020
Examining geographic accessibility to radiotherapy in Canada and Greenland for indigenous populations: Measuring inequities to inform solutionsJessica Chan, Jeppe Friborg, Eduardo Zubizarreta, et al.
Briefings in Bioinformatics|August 11, 2021
A genomic data resource for predicting antimicrobial resistance from laboratory-derived antimicrobial susceptibility phenotypesMargo VanOeffelen, Marcus Nguyen, Derya Aytan-Aktug, et al.
BMC Cancer|October 6, 2018
Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5Robert Olson, Mitchell Liu, Alanah Bergman, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 2022
Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized TrialMatthew Van Oirschot, Alanah Bergman, Wilko F A R Verbakel, et al.
JAMA Network Open|February 3, 2026
Stereotactic Body Radiotherapy Without Systemic Therapy for Oligometastatic Cancer: A Systematic Review and Meta-AnalysisJonas Willmann, Camilla von Wachter, Ronja Zehnder, et al.
Plos Biology|November 9, 2006
The marine viromes of four oceanic regionsFlorent E Angly, Ben Felts, Mya Breitbart, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2019
Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized TrialRobert Olson, Suresh Senan, Stephen Harrow, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2014
High-throughput comparison, functional annotation, and metabolic modeling of plant genomes using the PlantSEED resourceSamuel M D Seaver, Svetlana Gerdes, Océane Frelin, et al.
Biochimica Et Biophysica Acta|March 23, 2011
Connecting genotype to phenotype in the era of high-throughput sequencingChristopher S Henry, Ross Overbeek, Fangfang Xia, et al.
The American Journal of Pathology|July 25, 2021
Trajectory of Growth of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Houston, Texas, January through May 2021, Based on 12,476 Genome SequencesRandall J Olsen, Paul A Christensen, S Wesley Long, et al.
Pageof 13